144 related articles for article (PubMed ID: 101467)
1. Role of nonagglutinating antibody in the protracted immunity of vaccinated mice to Pseudomonas aeruginosa infection.
Moody MR; Kessel RW; Young VM; Fiset P
Infect Immun; 1978 Sep; 21(3):905-13. PubMed ID: 101467
[TBL] [Abstract][Full Text] [Related]
2. Pertussis antibodies in the sera of children exposed to Bordetella pertussis by vaccination or infection.
Dolby JM; Stephens S
J Hyg (Lond); 1973 Mar; 71(1):193-207. PubMed ID: 4348456
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
4. Passive protective properties of serum fractions from mice inoculated with an anti-pseudomonas vaccine.
Jones RJ; Hall M; Ricketts CR
Immunology; 1972 Dec; 23(6):889-95. PubMed ID: 4630781
[TBL] [Abstract][Full Text] [Related]
5. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II. Opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies.
Bjornson AB; Michael JG
Infect Immun; 1972 May; 5(5):775-82. PubMed ID: 4629252
[TBL] [Abstract][Full Text] [Related]
6. [The changes of the OEP-HA titer in the sera of mice challenged with Pseudomonas aeruginosa and in the phagocytic system of macrophages in vitro (author's transl)].
Satomi N; Haranaka K; Kunii O; Mashimo K
Kansenshogaku Zasshi; 1979 Aug; 53(8):350-8. PubMed ID: 119815
[No Abstract] [Full Text] [Related]
7. Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine.
Jones RJ; Roe EA
Br J Exp Pathol; 1975 Feb; 56(1):34-43. PubMed ID: 812544
[TBL] [Abstract][Full Text] [Related]
8. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
[TBL] [Abstract][Full Text] [Related]
9. Role of antibody in infections due to Pseudomonas aeruginosa.
Young LS
J Infect Dis; 1974 Nov; 130 Suppl(0):S111-8. PubMed ID: 4213568
[No Abstract] [Full Text] [Related]
10. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa.
Penketh AR; Pitt TL; Hodson ME; Batten JC
J Med Microbiol; 1983 Nov; 16(4):401-8. PubMed ID: 6417338
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-linked immunosorbent assay for detection of antibody to Pseudomonas aeruginosa and measurement of antibody titer in horse serum.
Ueda Y; Sanai Y; Homma JY
Am J Vet Res; 1982 Jan; 43(1):55-60. PubMed ID: 6807144
[TBL] [Abstract][Full Text] [Related]
12. Type-specific indirect hemagglutinating antibody in patients with Pseudomonas aeruginosa Infection.
Shigeta S; Yasunaga Y; Ogata M
J Clin Microbiol; 1978 Nov; 8(5):489-95. PubMed ID: 103887
[TBL] [Abstract][Full Text] [Related]
13. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
[TBL] [Abstract][Full Text] [Related]
14. Serum antibody and ocular responses to murine corneal infection caused by Pseudomonas aeruginosa.
Berk RS; Montgomery IN; Hazlett LD
Infect Immun; 1988 Dec; 56(12):3076-80. PubMed ID: 3141279
[TBL] [Abstract][Full Text] [Related]
15. Glycolipoprotein from Pseudomonas aeruginosa as a protective antigen against P. aeruginosa infection in mice.
Sensakovic JW; Bartell PF
Infect Immun; 1977 Nov; 18(2):304-9. PubMed ID: 411754
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M
Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
[TBL] [Abstract][Full Text] [Related]
17. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
[TBL] [Abstract][Full Text] [Related]
18. Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection.
Preston MJ; Berk JM; Hazlett LD; Berk RS
Infect Immun; 1991 Jun; 59(6):1984-90. PubMed ID: 1903770
[TBL] [Abstract][Full Text] [Related]
19. Immunological nonidentity of Pseudomonas paucimobilis with Pseudomonas aeruginosa and Pseudomonas cepacia.
Smalley DL; Ourth DD
J Clin Microbiol; 1980 Sep; 12(3):439-41. PubMed ID: 6783679
[TBL] [Abstract][Full Text] [Related]
20. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB
J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
